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Summary: Indices of oxidative stress in urine were measured in twenty patients undergoing elective coronary
artery bypass grafting. Hypoxanthine, xanthine and uric acid were measured in urine, as markers of ischaemia
together with malondialdehyde, which is a marker for lipid peroxidation. To correct for renal dysfunction during
coronary artery bypass grafting the creatinine concentration was measured in urine and plasma. The creatinine
concentration in plasma increases significantly during surgery, from 84 ± 23 μιηοΐ/ΐ to 133 ± 52 μπιοΙ/1, whereas
the creatinine concentration in urine decreases significantly, from 8.29 ± 4.45 mmol/1 to 2.70 ± 1.01 mmol/1, during
reperfusion. For reasons of comparison, the values of the observed measurements in urine are expressed per mol
creatinine. The hypoxanthine and xanthine excretions both increase significantly, from 15.0 ± 7.3 and 10.9 ± 5.7
mmol/mol creatinine, respectively, after induction of anaesthesia to a maximum of 33.1 ± 16.7 and 17.4 ± 11.1
mmol/mol creatinine, respectively, during reperfusion. The malondialdehyde excretion increases significantly, from
1.38 ± 0.80 mmol/mol creatinine after induction of anaesthesia to a maximum of 3.87 ± 1.87 mmol/mol creatinine
during reperfusion. The purines and malondialdehyde in urine (expressed as a ratio of creatinine), increase during
coronary artery bypass grafting as a consequence of oxygen mediated tissue injury.
Introduction
Oxygen is consumed by cells during the generation of
adenosine triphosphate, forming the energetic basis for
aerobic cell survival. In the presence of cytochrome oxi-
dase there is a stepwise tetravalent reduction of oxygen
to water. However, about 5% of oxygen is transformed
into water by a univalent pathway, in which several re-
active oxygen species are produced (1). Reactive oxygen
species may be generated under pathological circum-
stances such as radiation, ischaemia/reperfusion injury
and activated white blood cells (2). An increase of re-
active oxygen species activity can overwhelm local anti-
oxidant defence and cause damage to biological mole-
cules, especially DNA, lipids and proteins (3—5). Re-
active oxygen species play an important role in the
pathogenesis of postischaemic myocardial dysfunction
(myocardial "stunning", reperfusion injury) after acute
myocardial infarction, cardiac surgery and percutane-
ous transluminal coronary angioplasty (6—8). During
and after hypoxia or ischaemia there is, in the heart
as well as in other muscles, excessive breakdown of
adenosine triphosphate, which causes an efflux of
breakdown products like the purine derivatives. These
purine derivatives are thought to be good markers for
ischaemia, since they are able to pass through the cell
membrane and are released into blood. Malondialde-
hyde is one of the small-molecular-mass compounds
resulting from fragmentation of polyunsaturated fatty
acids undergoing reactive oxygen species attack, a fact
that qualifies this aldehyde as a marker of lipid peroxi-
dation (7, 17).
To identify the potential and actual damage in patients
undergoing coronary artery bypass grafting, the
following indices in urine are measured: hypoxanthine,
xanthine, uric acid and malondialdehyde. The observed
increase of the purines and malondialdehyde, confirmed
by other investigators (12, 13), could be explained by
the decrease in renal function that occurs during cardiac
surgery (14). Since events as haemolysis, hypotension,
hypothermia and non-pulsatile bloodflow during cardiac
pulmonary bypass can all contribute to impairment of
the renal function, it is not surprising that the purines
and malondialdehyde concentration in plasma increase
during these conditions.
In this paper we discuss a simple method for the simul-
taneous determination of the purines and malondialde-
hyde in urine as a result of oxidative stress. For reasons
of comparison, the concentration of hypoxanthine, xan-
thine, uric acid and malondialdehyde in urine are ex-
pressed as ratio of the urinary creatinine and are insensi-
tive for changes in renal function.
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Materials and Methods
Patients
Samples were taken from twenty patients undergoing elective first
time coronary artery bypass grafting. Seventeen patients were male
and three female with mean ages of 69 ± 13 years and 73 ± 4 years,
respectively. Mean time for cardiopulmonary bypass and for aortic
crossclampingwas 155 ± 19,respectively, 111 ± 16minutes.
Samples
Blood and urinary samples were obtained from patients during and
after coronary artery bypass grafting at specific time points, given
with their time-intervals (± SD):
1. After induction of anaesthesia; this time is set at: 0 minutes
2. During cardiopulmonary bypass and before aortic crossclamp-
ing; t = 105 ± 11 minutes
3. After aortic crossclamping until reperfusion; t = 140 ± 6 min-
utes
4. Reperfusion; t = 251 ± 16 minutes
5. Arrival Intensive Care Unit; t = 300 ± 19 minutes
6. The first postoperative day (8.00 a. m.)
Blood samples were taken from the radial artery and collected in
tubes containing respectively EDTA · K2 (final concentration 1.6 g/1
blood) or lithium heparin (final concentration 1.5 Χ 103 IU/1 blood).
Immediately after withdrawal the lithium heparin blood was placed
on ice. Plasma was obtained by centrifugation (lithium heparin
blood) at 1500 g for 10 minutes and the analyses were performed
within one hour. Urine specimens were collected during consecutive
time points as described above, using containers without any preser-
vative.
Reagents
HPLC-grade methanol, phosphoric acid 85% and potassium dihy-
drogenphosphate (Merck, Darmstadt, Germany), creatinine, tetra-
butylammoniumhydroxide, hypoxanthine, xanthine and uric acid
(Sigma Chemical Co, St Louis, MO, USA), malondialdehyde tetra-
butylammoniumhydroxide (Fluka AG, Buchs, Swiss) were
purchased from the respective suppliers.
Analyses
Albumin, creatinine and uric acid were determined by means of a
bromocresol purple dye-binding, a modification of the kinetic Jqffe
reaction and the uricase method, respectively, according to the
manufacturer's instructions (Dimension AR® analyzer (Dupont,
Wilmington, USA). The haematocrit value was determined on a
Coulter STKS® (Coulter Electronics Limited, Luton, England).
Measured values of the different indices in plasma are corrected
for haemodilution reported by Beaumont (10).
Corrected value =
measured value · Hc^ · (1 — Hct2)/Hct2 · (1 — Hcti)
In the above equation Hct! is the initial haematocrit of the first
sample (after induction of anaesthesia) and Hct2 is the sample
haematocrit. Hypoxanthine, xanthine and malondialdehyde were
determined by a slight modification of the HPLC method reported
by Lazzarino et al. (9).
HPLC
Aliquots of a urine specimen, filtered through a sterile acrodisc
filter 0.2 μιη (Gelman Sciences, Ann Arbor, Mi, USA), were ana-
lyzed by LKB-HPLC (Pharmacia Biotech AB, Uppsala, Sweden)
and separated on a 150 X 4.6 mm column of Supelco octadecyl
silica (Sulpelco Inc, Bellefonte, PA, USA) using a gradient elution.
Absorbance at 272 nm was monitored and data were collected with
a Perkin Elmer 500 series databox by use of Nelson Analytical
Chromatography Software, model 2600, Revision 5.0, 1987 (Per-
kin Elmer Cooperation, Norwalk, USA).
The HPLC method (9) was used to measure indices such as the
purines, adenosine triphosphate degradation products and malondi-
aldehyde in one run in plasma. The method was slightly modified.
Methanol was omitted in buffer A and the concentration was re-
duced from 30% to 20% in buffer B. The gradient for the Chroma-
tographie separation was as follows: 15 minutes at 100% of buffer
A, 15 minutes up to 100% of buffer B and hold for additional 6
minutes. The initial conditions were restored after 9 minutes of
washing with buffer A. Instead of plasma we used urine to deter-
mine the purines and malondialdehyde. Technical problems during
sample handling when plasma is used are thus prevented. A good
reproducibility of the method was found with an intra-run coeffi-
cient of variation of 1.1% for hypoxanthine, xanthine and uric acid
to 3.1% for malondialdehyde and a detection limit of 0.2 μηιοΐ/l,
for all indices. Thereby, the measurement of hypoxanthine, xan-
thine, uric acid and malondialdehyde in urine shows an excellent
resolution and peaks are easy to identify. However urine samples
stored by —70 °C are not stable and the values decrease in time
(result not shown). To minimize this storage effect all analyses
where performed within one hour.
Statistics
Comparisons between groups were made by repeated measures
using ANOVA and the Student's t-test. Ρ < 0.05 was considered




After induction of anaesthesia the mean haematocrit
value of the patients was 0.36 ± 0.03 1/1. During reper-
fusion the haematocrit decreased significantly to 0.23
± 0.02 1/1. The first postoperative day, the haematocrit
Tab. 1 Correction of indices in plasma according to the method of Beaumont
Time points Haematocrit* Corrected mean of the indices
After induction of anaesthesia
During cardiopulmonary bypass and before aortic crossclamping
After aortic crossclamping until reperfusion
Reperfusion
Arrival Intensive Care Unit
































* ρ < 0.05 by repeated measured ANOVA
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value was restored to 0.33 ± 0.02 1/1 without transfusion
of erythrocyte concentrate (tab. 1).
Albumin
After correction for haemodilution, the mean value of al-
bumin was 31.5 ± 2.5 g/1, which remains constant during
surgery, indicating that the correction as described by
Beaumont (10) is an acceptable correction (tab. 1).
Creatinine
During coronary artery bypass grafting the mean creati-
nine concentration in plasma increased significantly,
from 84 ± 23 μπιοΐ/ΐ after induction of anaesthesia to
134 ± 52 μηαοΐ/ΐ during reperfusion. At the first postop-
erative day the creatinine concentration decreased to 120
± 46 μηιοΐ/ΐ. During coronary artery bypass grafting
there is an accumulation of creatinine due to a decreased
renal function (fig. la, tab. 1).
induction of anaesthesia and increased significantly to
0.51 ±0.12 μιηοΐ/ΐ during reperfusion. At the first post-
operative day the uric acid concentration decreased
again to 0.38 ± 0.10 μπιοΐ/l (tab. 1). However, when
the concentration of uric acid is expressed as a ratio of
creatinine the concentrations of uric acid were almost
identical before, during, and after coronary artery bypass
grafting with a mean value of 0.29 ± 0.07 μηιοΐ/ΐ.
Measurements in urine
Creatinine
During coronary artery bypass grafting the mean creati-
nine concentration decreased significantly from 8.29
± 4.45 mmol/1 after induction of anaesthesia to 2.70
±1.01 mmol/1 during reperfusion. The first postopera-
tive day the mean creatinine concentration was increased
significantly, to a value of 6.90 ± 3.65 mmol/1 (fig. Ib,
tab. 2).
Uric acid
There is a strong increase in the concentration of uric
acid during coronary artery bypass grafting. The mean
concentration of uric acid was 0.28 ± 0.06 μηιοΐ/ΐ after
Uric acid
The profile of the uric acid concentration is identical to
the profile of the creatinine concentration during coronary
























Fig. 1 Creatinine in plasma and urine during coronary artery by-
pass grafting surgery at specific time points.
(a) Values are mean ± SD of creatinine in plasma of twenty sub-
jects (P < 0.05).
(b) Values are mean ± SD of creatinine in urine of twenty sub-

















Uric acid in urine during coronary artery bypass grafting surgery
at specific time points.
(c) Values are mean ± SD of uric acid in urine of twenty sub-
jects (P < 0.05).
(d) Values are mean ± SD of uric acid in urine of twenty subjects
expressed as ratio of urinary creatinine (P > 0.80).
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Tab. 2 Indices measured in urine
Time points
After induction of anaesthesia
During cardiopulmonary bypass and before aortic
crossclamping
After aortic crossclamping until reperfusion
Reperfusion
Arrival Intensive Care Unit










































* ρ < 0.05, *': ρ < 0.35; *2: ρ < 0.20 by repeated measures using ANOVA
decreases strongly during reperfusion. When the uric acid
values are expressed as ratio of the urinary creatinine,
there is no significant difference (p > 0.80) in time
(fig. Id).
Hypoxanthine
The mean hypoxanthine excretion expressed as ratio of
the urinary creatinine increased significantly, from 15.0
± 7.3 mmol/mol creatinine after induction of anaesthe-
sia to 33.1 ± 16.7 mmol/mol creatinine during reperfu-
sion. The first postoperative day the mean hypoxanthine
excretion decreased to the starting concentration of 19.1
±11.5 mmol/mol creatinine (fig. 2a).
Xanthine
The mean xanthine excretion, expressed as ratio of the
urinary creatmine, increased significantly, from 10.9
± 5.7 mmol/mol creatinine after induction of anaesthe-
sia, to a maximum of 18.9 ± 9.0 mmol/mol creatinine
at arrival on the Intensive Care Unit. At the first postop-
erative day, the mean xanthine excretion was lowered to
12.9 ± 9.9 mmol/mol creatinine (fig. 2b).
Malondialdehyde
The mean malondialdehyde excretion, expressed as ratio
of the urinary creatmine, increased significantly, from
1.38 ± 0.80 mmol/mol creatinine after induction of an-
aesthesia, to a maximum of 3.87 ± 1.87 mmol/mol cre-
atinine during reperfusion. At the first postoperative day
the mean value decreased significantly, to 0.87 ± 0.40
mmol/mol creatmine (fig. 2c).
Discussion
We evaluated indices of ischaemia and oxidative stress
in twenty patients undergoing elective first time coro-
nary artery bypass grafting. Although the myocardium
is well protected by cardioplegia during coronary artery
bypass grafting, there is still ischaemia resulting in
breakdown of adenosine triphosphate to hypoxanthine
and other degradation products (11). Activated prote-
ases, induced by Ca2+, convert the enzyme xanthine de-
hydrogenase into xanthine oxidase. During reperfusion,
hypoxanthine will be converted by xanthine oxidase to
xanthine and uric acid (19). Reactive oxygen species are
generated during the xanthine oxidoreductase route and
cause tissue injury (8, 15, 16).
The plasma concentrations of albumin, creatinine and
uric acid during coronary artery bypass grafting were
corrected for haemodilution (10). As expected, the cor-
rected concentration of albumin remains constant during
surgery indicating that the correction used is valid for
patients with haemodilution. The concentration of creati-
nine and uric acid increases strongly during coronary
artery bypass grafting. Other studies (12, 13) reported
increased concentrations of purines and malondialde-
hyde in plasma during coronary artery bypass grafting.
The observed increase of creatinine and uric acid and
the reported increase of hypoxanthine, xanthine and ma-
londialdehyde in plasma could both be explained by re-
nal dysfunction that occurs during cardiac surgery (14).
To determine the individual influence of hypotension
and non-pulsatile bloodflow during cardiac pulmonary
bypass, changes in creatinine in plasma as well in urine
are functionally good markers (14). Therefore all urinary
indices are expressed as a ratio of the creatinine concen-
tration in urine and are in this way insensitive to alter-
ations in renal function. Thereby, we assume that clear-
ance of small molecules such as creatinine and malondi-
aldehyde are comparable because these are only filtered
by the kidneys (passive excretion), whereas for uric acid
(and probably the purines) filtration, tubular reabsorp-
tion and tubular secretion are evident. In order to correct
and normalize all the indices in the same manner, we
express the indices as a ratio of the urinary creatinine.
The excretion of hypoxanthine, expressed as ratio of cre-
atinine, increases significantly, from 15.0 ± 7.3 mmol/
mol creatinine after induction of anaesthesia to a maxi-
mum of 33.1 ± 16.7 mmol/mol creatinine during reper-
fusion. Hypoxanthine was formed during the ischaemic
period of the myocardium (20). During reperfusion, hy-
poxanthine will be converted by xanthine oxidase to
xanthine and uric acid. A part of the produced hypoxan-
thine will be cleared by the kidneys in a time dependent
process. The excretion of xanthine increases signifi-
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cantly, from 10.9 ± 5.7 mmol/mol creatinine after in-
duction of anaesthesia to a maximum of 18.9 ± 9.0
mmol/mol creatinine at arrival on the Intensive Care
Unit. These results were as expected because the conver-
sion of hypoxanthine into xanthine took place after re-
perfiision. The first postoperative day the concentrations
of both indices decrease significantly to the starting
excretion of 19.1 ± 11.5 mmol/mol creatinine for hypo-
xanthine and 12.9 ± 9.9 mmol/mol creatinine for xan-
thine. After correction of the ischaemia of the myocar-































Fig. 2 Purines and malondialdehyde in urine during coronary ar-
tery bypass grafting surgery at specific time points.
(a) Values are mean ± SD of hypxanthine in urine of twenty sub-
jects expressed as ratio of urinary creatinine (P < 0.05).
(b) Values are mean ± SD of xanthine in urine of twenty subjects
expressed as ratio of urinary creatinine (P < 0.16).
(c) Values are mean ± SD of malondialdehyde in urine of twenty
subjects expressed as ratio of urinary creatinine (P < 0.05).
of adenosine triphosphate degradation products ceases.
The purines will be cleared by the kidney and the excre-
tion will normalize in time.
On the other hand, the excretion of uric acid decreases
strongly during reperfusion. Presenting the results of
uric acid as ratio of the creatinine in urine, there is no
significant difference between the time points for uric
acid (fig. Id). The expected increase of the concentration
of uric acid, which occurs as a result of the xanthine
oxidoreductase route due to ischaemia/reperfusion, did
not occur. Probably the method used is not sensitive
enough to discriminate between these small increases.
Moreover uric acid probably acts as an anti-oxidant, so
that the free radicals produced during ischaemia will be
trapped by uric acid whereby uric acid is converted into
allantoine (18).
In patients with heart failure the excretion of malondial-
dehyde was actually higher than that measured postoper-
atively as was reported earlier (12). We compared the
excretion of malondialdehyde of twenty healthy volun-
teers, mean excretion ± 1 SD: 0.20 ± 0.05 mmol/mol
creatinine, with the excretion of malondialdehyde from
the patients investigated, 1.38 ± 0.80 mmol/mol creati-
nine, undergoing elective first time coronary artery by-
pass grafting. There was a significant difference in the
excretion of malondialdehyde between the two groups
(p < 0.05), indicating that there was a difference in the
ischaemic status. During reperfusion the excretion of
malondialdehyde expressed as a ratio of creatinine
reaches a maximum of 3.87 ± 1.87 mmol/mol creatine.
At the first postoperative day the excretion of malondial-
dehyde decreases significantly, to 0.87 ± 0.40 mmol/
mol creatinine, indicating less ischaemic myocardium
and that the intervention was successful. For logistic
reasons we stopped sampling after the first post-opera-
tive day. No data are available about the concentration
of malondialdehyde over time.
In general, the excretion of the purines, hypoxanthine,
xanthine and uric acid, measured during coronary artery
bypass grafting, is still increased despite the correction
for creatinine as an indicator for renal function. The
increase of the concentrations of purines and malondial-
dehyde in plasma is probably caused by a reduced clear-
ance of these products by the kidneys instead of by
ischaemic reperfusion injury (13). Comparing the excre-
tions of purines and malondialdehyde, corrected for
changes in renal function in time, gives a good impres-
sion of the oxidative tissue injury by reactive oxygen
species.
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